Literature DB >> 15032302

Solubilizing excipients in oral and injectable formulations.

Robert G Strickley1.   

Abstract

A review of commercially available oral and injectable solution formulations reveals that the solubilizing excipients include water-soluble organic solvents (polyethylene glycol 300, polyethylene glycol 400, ethanol, propylene glycol, glycerin, N-methyl-2-pyrrolidone, dimethylacetamide, and dimethylsulfoxide), non-ionic surfactants (Cremophor EL, Cremophor RH 40, Cremophor RH 60, d-alpha-tocopherol polyethylene glycol 1000 succinate, polysorbate 20, polysorbate 80, Solutol HS 15, sorbitan monooleate, poloxamer 407, Labrafil M-1944CS, Labrafil M-2125CS, Labrasol, Gellucire 44/14, Softigen 767, and mono- and di-fatty acid esters of PEG 300, 400, or 1750), water-insoluble lipids (castor oil, corn oil, cottonseed oil, olive oil, peanut oil, peppermint oil, safflower oil, sesame oil, soybean oil, hydrogenated vegetable oils, hydrogenated soybean oil, and medium-chain triglycerides of coconut oil and palm seed oil), organic liquids/semi-solids (beeswax, d-alpha-tocopherol, oleic acid, medium-chain mono- and diglycerides), various cyclodextrins (alpha-cyclodextrin, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, and sulfobutylether-beta-cyclodextrin), and phospholipids (hydrogenated soy phosphatidylcholine, distearoylphosphatidylglycerol, L-alpha-dimyristoylphosphatidylcholine, L-alpha-dimyristoylphosphatidylglycerol). The chemical techniques to solubilize water-insoluble drugs for oral and injection administration include pH adjustment, cosolvents, complexation, microemulsions, self-emulsifying drug delivery systems, micelles, liposomes, and emulsions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032302     DOI: 10.1023/b:pham.0000016235.32639.23

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  45 in total

1.  Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.

Authors:  G A Brazeau; H L Fung
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Solubility principles and practices for parenteral drug dosage form development.

Authors:  S Sweetana; M J Akers
Journal:  PDA J Pharm Sci Technol       Date:  1996 Sep-Oct

3.  Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injection.

Authors:  G A Brazeau; H L Fung
Journal:  J Parenter Sci Technol       Date:  1989 Jul-Aug

Review 4.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

5.  Review of excipients and pH's for parenteral products used in the United States.

Authors:  Y C Wang; R R Kowal
Journal:  J Parenter Drug Assoc       Date:  1980 Nov-Dec

6.  Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.

Authors:  J Napaporn; M Thomas; K A Svetic; Z Shahrokh; G A Brazeau
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

7.  Lysis of human red blood cells 1: Effect of contact time on water induced hemolysis.

Authors:  J F Krzyzaniak; D M Raymond; S H Yalkowsky
Journal:  PDA J Pharm Sci Technol       Date:  1996 Jul-Aug

8.  Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin.

Authors:  A Y Tinwalla; B L Hoesterey; T X Xiang; K Lim; B D Anderson
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.

Authors:  Erin D Hugger; Barbara L Novak; Philip S Burton; Kenneth L Audus; Ronald T Borchardt
Journal:  J Pharm Sci       Date:  2002-09       Impact factor: 3.534

10.  Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.

Authors:  Erin D Hugger; Kenneth L Audus; Ronald T Borchardt
Journal:  J Pharm Sci       Date:  2002-09       Impact factor: 3.534

View more
  152 in total

1.  Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.

Authors:  Yangjie Wei; Michael P Nedley; Sarit B Bhaduri; Xavier Bredzinski; Sai H S Boddu
Journal:  AAPS PharmSciTech       Date:  2014-11-01       Impact factor: 3.246

2.  A bifunctional dimethylsulfoxide substitute enhances the aqueous solubility of small organic molecules.

Authors:  Melissa M Sprachman; Peter Wipf
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

Review 3.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

4.  Formulation development of parenteral phospholipid-based microemulsion of etoposide.

Authors:  Jayesh Jain; Clara Fernandes; Vandana Patravale
Journal:  AAPS PharmSciTech       Date:  2010-05-13       Impact factor: 3.246

5.  Solubility of pioglitazone hydrochloride in binary and ternary mixtures of water, propylene glycol, and polyethylene glycols 200, 400, and 600 at 298.2 k.

Authors:  Abolghasem Jouyban; Shahla Soltanpour
Journal:  AAPS PharmSciTech       Date:  2010-11-30       Impact factor: 3.246

6.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

7.  Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.

Authors:  Robert A Mook; Jiangbo Wang; Xiu-Rong Ren; Minyong Chen; Ivan Spasojevic; Larry S Barak; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem       Date:  2015-08-10       Impact factor: 3.641

8.  Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.

Authors:  Seulki Lee; Sang Kyoon Kim; Dong Yun Lee; Su Young Chae; Youngro Byun
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

9.  Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Mengxin Geng; Akshaya Ravichandran; Jerome Escano; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.

Authors:  Xiang Ling; Jiasheng Tu; Junqing Wang; Aram Shajii; Na Kong; Chan Feng; Ye Zhang; Mikyung Yu; Tian Xie; Zameer Bharwani; Bader M Aljaeid; Bingyang Shi; Wei Tao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-12-04       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.